AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLARITY PHARMACEUTICALS LTD

2.480

0.000

Volume:257.58K

Turnover:638.91K

Market Cap:922.63M

PE:-8.79

High:2.510

Open:2.470

Low:2.440

Close:2.480

52wk High:5.870

52wk Low:1.800

Shares:372.03M

Float Shares:274.26M

Volume Ratio:0.95

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.282

EPS(LYR):-0.201

ROE:-53.45%

ROA:-30.54%

PB:3.96

PE(LYR):-12.31

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Clarity Pharmaceuticals - Reports Two Additional Complete Responses in Secure Trial at 8 Gbq Dose

THOMSON REUTERS

Clarity Pharmaceuticals - 74% Achieve Psa25, 63% Psa50, 53% Psa75, 26% Psa90 in Secure Trial at 8 Gbq

THOMSON REUTERS

Clarity Pharmaceuticals - Most Adverse Events at 8 Gbq Dose were Mild or Moderate and Transient

THOMSON REUTERS

Clarity Pharmaceuticals - 81% Achieve Disease Control, 31% Complete Response/Undetectable Disease at 8 Gbq Dose

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/CU6.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CU6.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CU6.AU\",,,,,undefined,":{"symbol":"CU6.AU","market":"AU","secType":"STK","nameCN":"CLARITY PHARMACEUTICALS LTD","latestPrice":2.48,"timestamp":1787705212888,"preClose":2.48,"halted":0,"volume":257575,"delay":0,"changeRate":0,"nameEN":"CLARITY PHARMACEUTICALS LTD","floatShares":274264090,"shares":372030071,"eps":-0.282253,"marketStatus":"Trading","change":0,"latestTime":"08-26 10:47:01 AEST","open":2.47,"high":2.51,"low":2.44,"amount":638909,"amplitude":0.028226,"askPrice":2.49,"askSize":21053,"bidPrice":2.47,"bidSize":11897,"shortable":3,"etf":0,"ttmEps":-0.282253,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787724000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.48,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":0.947791,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CU6.AU","preClose":2.48,"auctionPrice":2.47,"auctionVolume":12095,"auctionTime":1787702352433,"referenceTime":1787653803093,"auction":1,"marketStatus":"盘前竞价","timestamp":1787702352433}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CU6.AU\",,,,,undefined,":{"symbol":"CU6.AU","floatShares":274264090,"roa":"-30.54%","roe":"-53.45%","lyrEps":-0.201427,"volumeRatio":0.947791,"shares":372030071,"dividePrice":0,"high":2.51,"amplitude":0.028226,"preClose":2.48,"low":2.44,"week52Low":1.8,"pbRate":"3.96","psRate":"87.21","week52High":5.87,"institutionHeld":0,"latestPrice":2.48,"committee":-0.277876,"eps":-0.282253,"divideRate":0,"volume":257575,"delay":0,"ttmEps":-0.282253,"open":2.47,"prevYearClose":3.38,"prevWeekClose":2.48,"prevMonthClose":2.37,"prevQuarterClose":2.14,"fiveDayClose":2.49,"twentyDayClose":2.09,"sixtyDayClose":2.36,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CU6.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CU6.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CU6.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657679547","title":"Clarity Pharmaceuticals - Reports Two Additional Complete Responses in Secure Trial at 8 Gbq Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2657679547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657679547?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:05","pubTimestamp":1785935112,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547678","title":"Clarity Pharmaceuticals - 74% Achieve Psa25, 63% Psa50, 53% Psa75, 26% Psa90 in Secure Trial at 8 Gbq","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547678?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:05","pubTimestamp":1785935112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421K3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547674","title":"Clarity Pharmaceuticals - Most Adverse Events at 8 Gbq Dose were Mild or Moderate and Transient","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547674","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547674?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:05","pubTimestamp":1785935112,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421K3:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657547673","title":"Clarity Pharmaceuticals - 81% Achieve Disease Control, 31% Complete Response/Undetectable Disease at 8 Gbq Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2657547673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657547673?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:05","pubTimestamp":1785935112,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4421K3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","CU6.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CU6.AU\",params:#limit:6,delay:true,,,undefined,":[]}}